Format of Original
8 p.; 23 cm
Journal of Anxiety Disorders
Original Item ID
doi: 10.1016/j.janxdis.2015.09.008; PubMed Central, PMCID: PMC4658278; Shelves: RC 531 .J68 2015 v. 36, Memorial Periodicals
The Massachusetts General Hospital Hairpulling Scale (MGH-HPS) and the NIMH Trichotillomania Severity Scale (NIMH-TSS) are two widely used measures of trichotillomania severity. Despite their popular use, currently no empirically-supported guidelines exist to determine the degrees of change on these scales that best indicate treatment response. Determination of such criteria could aid in clinical decision-making by defining clinically significant treatment response/recovery and producing accurate power analyses for use in clinical trials research. Adults with trichotillomania (N = 69) participated in a randomized controlled trial of psychotherapy and were assessed before and after treatment. Response status was measured via the Clinical Global Impressions-Improvement Scale, and remission status was measured via the Clinical Global Impressions-Severity Scale. For treatment response, a 45% reduction or 7-point raw score change on the MGH-HPS was the best indicator of clinically significant treatment response, and on the NIMH-TSS, a 30–40% reduction or 6-point raw score difference was most effective cutoff. For disorder remission, a 55–60% reduction or 7-point raw score change on the MGH-HPS was the best predictor, and on the NIMH-TSS, a 65% reduction or 6-point raw score change was the best indicator of disorder remission. Implications of these findings are discussed.
Houghton, David C.; Capriotti, Matthew R.; De Nadai, Alessandro S.; Compton, Scott N.; Twohig, Michael P.; Neal-Barnett, Angela M.; Saunders, Stephen M.; Franklin, Martin E.; and Woods, Douglas W., "Defining Treatment Response in Trichotillomania: A Signal Detection Analysis" (2015). Psychology Faculty Research and Publications. 180.